T. Rowe Price Health Sciences Fund (PRHSX) - Health fund with $12.45 Billion in assets. The fund allocates 45.30% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is ELI LILLY CO at 14.28% of total assets. This is followed by UNITEDHEALTH GROUP INC (5.99%) and INTUITIVE SURGICAL INC (3.65%).
| Name | Weight | Owned | Change |
|---|---|---|---|
| ELI LILLY CO | 14.28% | - | - |
| UNITEDHEALTH GROUP INC | 5.99% | - | - |
| INTUITIVE SURGICAL INC | 3.65% | - | - |
| THERMO FISHER SCIENTIFIC INC | 2.52% | - | - |
| MERCK CO INC | 4.01% | - | - |
| ELEVANCE HEALTH INC | 3.73% | - | - |
| STRYKER CORP | 3.46% | - | - |
| DANAHER CORP | 2.73% | - | - |
| REGENERON PHARMACEUTICALS INC | 2.65% | - | - |
| VERTEX PHARMACEUTICALS INC | 2.28% | - | - |
| ARGENX SE | 2.92% | - | - |
| BOSTON SCIENTIFIC CORP | 2.51% | - | - |
| ALNYLAM PHARMACEUTICALS INC | 3.29% | - | - |
| ABBVIE INC | 5.10% | - | - |
| INSMED INC | 3.04% | - | - |
| GILEAD SCIENCES INC | 2.82% | - | - |
| ASTRAZENECA PLC | 3.17% | - | - |
| JOHNSON JOHNSON | 6.63% | - | - |
| BRISTOL-MYERS SQUIBB CO | 2.11% | - | - |
| ABBOTT LABORATORIES | 1.89% | - | - |